Duration: 1 hour
Dr Amar Thyagarajan
Global Strategy Head &
Head of NA BD
Principal Scientific Manager
Did you miss Aragen’s recent webinar on Targeted Protein Degradation in Inflammation and Cancer Therapy? You can now access the recorded webinar and the Q&A transcript of the session by filling out a quick form.
The webinar focuses on our efforts with PROTACs in the areas of Inflammation and Cancer. Our speakers discuss challenges and opportunities to develop PROTACs in the areas of Autoimmune and Inflammatory Diseases driven by IL-1R/TLR1 signaling and inflammasome activation, and in potentially undruggable epigenetic pathways that involve bromodomain proteins, histone acetyltransferases and deacetylases.
During this session, you will learn about: